Hudens Bio
Hudens Bio is a leading company in South Korea, established in 2013. We focus on producing innovative dental materials using metals, ceramics, and polymers. Our headquarters is in Gwangju, with our lab in Daegu and our global office in Seoul. In 2018, we expanded our global presence by opening a joint venture office in Sichuan, China, with Huaguang, a top dental distributor. Our revenue primarily comes from markets in India, Japan, China, the Middle East, and Southeast Asia. Our bur products, especially the Burstar-HP, are particularly popular in India, and we also export our polymer products to China, India, and the Philippines. In 2020, we developed OCP bone graft material, which uses advanced biomimetic technology to significantly enhance bone regeneration. The OCP material is a precursor to biological HA, a mineral found in human bones, and it helps accelerate the healing process. Our technology is protected as a national technology in South Korea, and we hold patents in multiple countries. We are conducting extensive testing to ensure its safety and effectiveness. In July 2022, we formed a significant sales agreement with Geistlich Pharma in Switzerland, allowing them to sell our OCP product in Korea. They recognized its potential and validated its efficacy through their own tests. We also have a Key Opinion Leader (KOL) advisory board made up of respected doctors in South Korea. With their support, we successfully launched the Bone Regeneration Forum, OCPOLOGY, in January 2024 and 2025, which attracted 300 doctors and received positive feedback from the dental community. Additionally, we are collaborating with several university hospitals to achieve strong clinical outcomes through our research. As we continue to diversify our product portfolio, moving from dental products to bio-level specialties, we take pride in our reputation as a top-tier manufacturer of dental materials.
